E-cadherin and beta-catenin expression in Epstein-Barr virus-associated gastric carcinoma and their prognostic significance

Table 2 Membranous and nuclear and/or cytoplasmic expression of beta-catenin in EBV-GCs and non EBV-GCs

Location ofbeta-catenin expression	Number of the cases (%)		OR1	95% CI1
	EBV-GCs	non EBV-GCs
Total	59	120
Membranous
Preserved (> 10%)	49 (83)	78 (65)	1	Referent
Lost (< 10%)	10 (17)	42 (35)	0.41	0.19-0.90
Nuclei and cytoplasm
Negative	46 (78)	106 (88)	1	Referent
Positive (subtotal)	13 (22)	14 (12)	2.23	0.97-5.09
10%-	5 (8)	8 (7)	1.48	0.47-4.66
50%-	6 (10)	6 (5)	2.34	0.74-7.36
90%-	2 (3)	0 (0)	-
			P = 0.024

¹ORs and 95% CIs were obtained from conditional logistic regression analysis with the objective variable being EBV-GC (EBV-GC = 1, and non EBV-GC = 0).